Attached files

file filename
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42020ex311.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcjazzq42020ex321.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42020ex312.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Jazz Pharmaceuticals plcjazzq42020ex231.htm
EX-10.33D - CASH BONUS PLAN (IRELAND AND OTHER) - Jazz Pharmaceuticals plcjazzq42020ex1033d.htm
EX-10.33C - CASH BONUS PLAN U.S. - Jazz Pharmaceuticals plcjazzq42020ex1033c.htm
EX-10.12 - AMENDED AND RESTATED LICENSE AGREEMENT - Jazz Pharmaceuticals plcjazzq42020ex1012.htm
EX-10.8 - MANUFACTURING SERVICES AGREEMENT - Jazz Pharmaceuticals plcjazzq42020ex108.htm
EX-4.7 - DESCRIPTION OF SHARE CAPITAL - Jazz Pharmaceuticals plcjazzq42020ex47.htm
10-K - 10-K - Jazz Pharmaceuticals plcjazz-20201231.htm

Exhibit 21.1
Subsidiaries of the Registrant


NameState/Jurisdiction of Incorporation
Jazz Pharmaceuticals Ireland LimitedIreland
Jazz Financing I DACIreland
Jazz Capital LtdIreland
Jazz Pharmaceuticals, Inc.Delaware
Celator Pharmaceuticals, IncDelaware
Jazz Pharmaceuticals Europe Holdings LimitedGibraltar
Jazz Investments Europe LimitedMalta
Jazz Pharmaceuticals France SASFrance
Gentium S.r.L.Italy
Jazz Pharmaceuticals International LimitedBermuda
Jazz Investments I LimitedBermuda
Jazz Pharmaceuticals UK LimitedUnited Kingdom